A common stomach bug may be linked to one in five bowel cancers

What happened

A study published in the open access journal eGastroenterology has estimated that exposure to a common stomach bacterium may be linked to more than one in five cases of bowel cancer around the world. The bacterium is Helicobacter pylori, usually shortened to H. pylori. Many people have heard of it as the bug behind stomach ulcers. It is very common. It lives in the lining of the stomach, often picked up in childhood, and in most people it causes no symptoms at all. Researchers pulled together data from 43 separate studies covering nearly 48.7 million people. They compared bowel cancer rates in people who had been exposed to H. pylori with rates in people who had not. They found that people exposed to the bacterium had roughly a 1.6 times higher risk of bowel cancer. Applying that to global cancer figures from 2022, the team estimated that around 22 per cent of bowel cancer cases worldwide could potentially be attributed to H. pylori exposure. The analysis also suggested that people born in more recent decades may carry more of this risk after exposure than earlier generations did. The researchers were clear about the next step. They said high quality, long term studies are now needed to find out whether clearing the bacterium with antibiotics actually lowers bowel cancer risk.

Why this matters

Bowel cancer is one of the most common cancers in the UK and worldwide. Anything that might explain a large slice of it is worth taking seriously. What makes this particular finding interesting is that H. pylori is treatable. It is cleared with a short course of antibiotics combined with a medicine that reduces stomach acid. This is already routine NHS practice for people with stomach ulcers or certain digestive symptoms, and for some people at higher risk of stomach cancer. So if the link turns out to be causal, there is already a treatment sitting on the shelf. That is a rare and hopeful position to be in. Most cancer risk factors are much harder to change. There is also a note of caution in the finding about younger generations. Bowel cancer in younger adults has been rising in several countries, and nobody fully understands why. This study does not solve that puzzle, but it adds a thread worth pulling. The honest position today is that this is an important lead, not a finished answer.

What the evidence actually says

This is the part that deserves care, because the headline number is easy to misread. The study is what researchers call a risk attribution modelling study. It does not follow people forward in time and watch what happens. It takes existing studies, works out an average association, and then estimates how much of the global disease burden that association could account for. That method has real value for spotting priorities. It also has real limits. The main limit is that association is not causation. People exposed to H. pylori may differ from people who are not in other ways, including diet, income, access to healthcare and childhood living conditions. Good studies adjust for some of this. None can adjust for everything. The word "potentially" in the researchers' own summary is doing a lot of work, and they chose it deliberately. Twenty-two per cent is what you would get if the whole association were causal. If only part of it is, the true figure is smaller. A 1.6 times increase also sounds larger than it feels in practice. It is a relative figure. Your personal risk depends on your starting risk, which is shaped by age, family history, weight, smoking, alcohol and diet. The researchers themselves called the work exploratory and said eradication trials are needed. That is the correct read. Nobody is recommending that everyone be tested and treated for H. pylori to prevent bowel cancer. Not yet, and possibly not ever.

Qurexa perspective

There is one practical thread here that we deal with every week: finishing an antibiotic course properly. Treatment to clear H. pylori is not a single tablet. It is usually two antibiotics plus an acid-reducing medicine, taken together, twice a day, for around a week to ten days. It can cause a metallic taste, an upset stomach or tiredness, and that combination makes it one of the courses people are most likely to abandon partway through. Stopping early matters more than usual here, because a partly treated infection can come back and the bacteria can become harder to clear next time. Qurexa supports people in Lincolnshire with prescription delivery and medication adherence, and short intensive courses like this are a good example of where a reminder and a doorstep delivery genuinely help. If you have been prescribed eradication treatment and you are struggling with it, the right move is to speak to your pharmacist rather than quietly stop.

Practical advice

**Do not ask for an H. pylori test because of this study alone.** There is no evidence yet that testing and treating healthy people without symptoms prevents bowel cancer, and unnecessary antibiotics carry their own risks. **Do get persistent stomach symptoms checked.** Indigestion that keeps coming back, pain in the upper stomach, feeling full quickly, or unexplained nausea are all reasons to see your GP. H. pylori testing may be part of what they arrange, for reasons that already have good evidence behind them. **Take bowel screening seriously.** This is the single most useful thing in this article. In England, NHS bowel cancer screening is offered by post to people aged 50 to 74, with the age range having been extended in stages. Scotland, Wales and Northern Ireland run their own programmes with slightly different ages. The test is a small sample you take at home and post back. It finds cancers early, when they are far more treatable. **Know the symptoms that need checking now, at any age.** Blood in your poo, a lasting change in your bowel habit, unexplained weight loss, persistent tummy pain, or tiredness that is not explained. Screening is for people without symptoms. If you have symptoms, do not wait for a kit. **Do the things with solid evidence behind them.** Not smoking, keeping alcohol modest, staying active, eating more fibre and less processed red meat, and keeping to a healthy weight all reduce bowel cancer risk. None of that is new, which is rather the point.

What to know

Researchers pooled data on nearly 48.7 million people and found that exposure to H. pylori was associated with about a 1.6 times higher risk of bowel cancer. Scaled up to global figures, they estimated around 22 per cent of cases could potentially be linked to the bacterium. This is an early, exploratory finding from modelling, not proof that the bug causes bowel cancer, and not a reason to be tested if you have no symptoms. What it does is give researchers a strong reason to run proper trials on whether clearing the infection changes anything. Meanwhile, the advice that already works has not changed. If a bowel screening kit lands on your doormat, do it and post it back. If you have symptoms, see your GP now. Those two actions save more lives than any headline. Sources: BMJ Group, "Helicobacter pylori exposure may be linked to more than 1 in 5 bowel cancer cases worldwide", 10 September 2026, https://bmjgroup.com/helicobacter-pylori-exposure-may-be-linked-to-more-than-1-in-5-bowel-cancer-cases-worldwide/ ; News-Medical, "Helicobacter pylori exposure linked to one in five cases of bowel cancer", 8 September 2026, https://www.news-medical.net/news/20260908/Helicobacter-pylori-exposure-linked-to-one-in-five-cases-of-bowel-cancer.aspx ; Science Media Centre, "Expert reaction to a risk attribution modelling study on global and regional burden of colorectal cancer potentially related to Helicobacter pylori exposure", September 2026, https://www.sciencemediacentre.org/expert-reaction-to-a-risk-attribution-modelling-study-on-global-and-regional-burden-of-colorectal-cancer-potentially-related-to-helicobacter-pylori-exposure/ This article is for general information and does not replace advice from a doctor, pharmacist or other qualified healthcare professional. If you have bowel symptoms that worry you, contact your GP practice.